| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $69.6M | -17.7% |
| Cost of Revenue | $53.9M | -6.8% |
| R&D Expense | $50.3M | +2.8% |
| SG&A Expense | $53.6M | +16.0% |
| Operating Income | -$88.1M | -29.0% |
| Interest Expense | $205K | +754.2% |
| Pre-tax Income | -$81.2M | +0.0% |
| Income Tax | $21K | +16.7% |
| Net Income | -$81.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.2M | +35.9% |
| Short-term Investments | $115.7M | +23.6% |
| Accounts Receivable | $16.2M | +99.1% |
| Current Assets | $268.0M | +32.0% |
| Total Assets | $334.2M | +23.6% |
| Current Liabilities | $39.6M | +27.3% |
| Total Liabilities | $73.0M | +8.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.9M | -66.0% |
| Capital Expenditures | $4.5M | +181.0% |
| Investing Cash Flow | -$22.6M | +35.6% |
| Financing Cash Flow | $130.3M | +13.7% |
| Free Cash Flow | -$79.5M | -69.9% |
| +0.0% |
| EPS (Basic) | -$0.91 | +33.6% |
| EPS (Diluted) | -$0.91 | +33.6% |
| Stockholders' Equity |
| $261.2M |
| +28.7% |